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Non-technical Summary 
 
Pain is conveyed to the brain by nerve impulses produced by specialised membrane proteins 
called sodium channels.  We show here that a membrane molecule derived from the venom of a 
marine cone snail can be used to produce genetic inactivation of these channels and suppress 
pain in mice without requiring repeated applications of the toxin. These studies provide a new 
mouse model to help understand the role of these sodium channels in pain and offer promise for 
novel analgesic interventions based on gene therapy.  
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Abstract 
 
 
Understanding information flow in sensory pathways requires cell-selective 
approaches to manipulate the activity of defined neurones. Primary afferent nociceptors, which 
detect painful stimuli, are enriched in specific voltage-gated sodium channel (VGSC) subtypes. 
Toxins derived from venomous animals can be used to dissect the contributions of particular 
ion currents to cell physiology. Here we have used a transgenic approach to target a 
membrane-tethered isoform of the conotoxin MrVIa (t-MrVIa) only to nociceptive neurones in 
mice.  t-MrVIa transgenic mice show a  44 ± 7 % reduction of tetrodotoxin resistant (TTX-R) 
VGSC current densities. This inhibition is permanent, reversible and does not result in 
functional upregulation of TTX-sensitive (TTX-S) VGSC, voltage-gated calcium currents (VGCC) 
or transient receptor potential (TRP) channels present in nociceptive neurones. As a 
consequence of the reduction of VGSC currents, t-MrVIa transgenic mice display decreased 
inflammatory mechanical hyperalgesia, cold pain insensitivity and reduced firing of cutaneous 
C-fibres sensitive to noxious cold temperatures. These data validate the use of genetically 
encoded t-toxins as a powerful tool to manipulate VGSC in specific cell types within the 
mammalian nervous system. This novel genetic methodology can be used for circuit mapping 
and has the key advantage that it enables to dissect the contribution of specific ionic currents 
to neuronal function and to behaviour. 
 
 
Abbreviations BAC, bacterial artificial chromosome; DRG, dorsal root ganglion; GPI, 
glycophosphatidylinositol; IB4, isolectin-B4; PI-PLC, phosphatidylinositol-specific phospholipase C; t-
MrVIa, membrane-tethered conotoxin MrVIa; TTX, tetrodotoxin; TTX-R, tetrodotoxin resistant; VGSC, 
Voltage-gated sodium channel.  
 
 
 
 3 
Introduction 
Neuronal communication relies on action potentials (APs) generated by the activity of voltage-gated 
sodium channels (VGSC) following membrane depolarisation. The alkaloid toxin tetrodotoxin (TTX) 
has been exploited for more than 40 years due to its unique ability to block VGSC and therefore to 
assess the contribution of these channels to cell excitability and AP propagation. Nociceptive sensory 
neurones (nociceptors) detect noxious peripheral stimuli, this information is then transmitted to the 
superficial dorsal horn of the spinal cord, relayed to the brain, and perceived as pain (Lewin 
&Moshourab 2004). Nociceptors express two unusual VGSCs, Nav1.8 and Nav1.9, which are resistant 
to TTX (Akopian et al. 1999; Dib-Hajj et al. 1998).  Nav1.8 generates sodium currents with a high 
activation threshold (–40 mV) and slow inactivation (Akopian et al. 1999; Renganathan et al. 2002; 
Sangameswaran et al. 1997), whereas Nav1.9 produces a persistent current with a more 
hyperpolarised voltage dependence and ultraslow recovery from inactivation (Baker 2005; Cummins et 
al. 2007). In addition nociceptors are enriched in the Nav1.7 TTX-S VGSC subtype (Nassar et al. 
2004) which produces the threshold currents (Matsutomi et al. 2006). Small molecules that specifically 
block the function of these VGSC subtypes include chemical tools (Jarvis et al. 2007), small interfering 
RNAs (Dong et al. 2007), and venom derived toxins (Terlau &Olivera 2004). The μO-conotoxins MrVIa 
and MrVIb were the first group of peptide toxins reported to inhibit VGSC currents in mammalian 
dorsal root ganglia (DRG) neurones (Daly et al. 2004). MrVIa was found to inhibit TTX-R VGSC 
currents with an IC50value of ~80 nM and a ~ 10 times higher IC50value (~ 1 μM) for TTX-S sodium 
currents ((Daly et al. 2004), Supplemental Table 1).  
In this study we have used the tethered toxin approach (Holford et al. 2009; Ibañez-Tallon et 
al. 2004) combined with cell-specific transgenesis, to deliver a genetically encoded tethered form of 
the neurotoxin MrVIa to nociceptors in mice. We show that this approach can be successfully used to 
manipulate VGSC currents in a cell-autonomous manner. Furthermore, the nociceptor specific 
inhibition of VGSC currents in these transgenic mice leads to specific changes in the firing of noxious 
cold sensitive nociceptors and reduction in inflammation induced pain behaviour. 
 
 
Methods 
 
Mice were housed in the animal facility of the Max-Delbrück Center with ad libitum access to food and 
water in room air conditioned at 22-230C with a standard 12h light/dark cycle. Mice were killed by 
placement in a CO2-filled chamber for a 2–4 min followed by cervical dislocation. All procedures 
conformed to the German guidelines of animal experimentation laid down by the government. Animal 
housing and care as well as protocols for sacrificing mice, are registered with and approved by the 
appropriate German federal authorities (Landesamt für Gesundheit und Soziales), which also 
governed proper implementation.  
 
Generation of Tg-t-MrVIa BAC transgenic mice 
The mouse BAC clone (RP23-214H2) encompassing the Scn10a gene (Invitrogen) was modified to 
include the t-MrVIa expression cassette using the two-step recombination system (Gong et al. 2002). 
After electroporation and homologous recombination, resolved clones were screened by PCR and 
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Southern Blotting. The modified BAC for injection was purified by CsCl, linearised and 3 ng/µl of BAC 
DNA were injected into fertilised oocytes of hybrid BDF mice.  
 
Southern blot analyses 
Genomic DNA (5 µg) from each transgenic founder line was digested with NcoI and separated by gel 
electrophoresis. After gel denaturation (0.5M NaOH, 1.5M NaCl) and equilibration  
(10 x SSC), membrane blotting (Hybond N+ from Amersham) was performed in 10x SSC. The 
membrane was quickly washed in 2x SSC dried for 2h and crosslinked with UV light (Hoefer). DNA 
probes were radioactively labeled with α-32p-dCTP (NEN) using the Prime-ItRmT Random primer 
Labelling kit (Stratagene). 25ng of the probe were purified via Probe-Quant G50 micro-columns 
(Amersham) and denatured at 950C for 5min before hybridisation. Hybridisation was performed at 
650C overnight in 5x Denhardt’s solution, 6x SSC, 0.5% SDS and 100µg/ml salmon sperm DNA. The 
membrane was washed in 2x SSC/0.1% SDS followed by stringent washes in 0.1x SSC/0.1% SDS . 
Autoradiograms were exposed at -700C for 3 days. 
 
Real time PCR (RT-PCR)  
Mouse tissues were rapidly dissected, collected in Trizol and homogenised. Total RNA was extracted 
by phenol/chloroform and DNaseI (Invitrogen) treated. RT-PCRs were performed using one step 
platinum RT-PCR (Invitrogen). Primer pairs  used were: t-MrVIa-F: 5’–TGGGAGTACTGCATAGTGCC 
GAT–3’,t-MrVIa-R:5’–CCCGTAGTTCCATCCTTCCTTCAA–3’,Nav1.8-F:5’–TAACGTGTGGGTCTCTG 
TGC–3’,Nav1.8-R:5’–AGGTATGGAGCCAGGTCCTC–3’, β-actin-F:5’-TCGTGCGTGACATCAAAGAG 
AAGC–3’,β-actin-R:5’–ATGGATGCCACAGGATTCCATACC–3’ 
 
In situ hybridisation  
RNA probes were synthesised with T7 RNA polymerase using DIG labeling (Roche) and purified with 
the RNeasy kit (Qiagen). Dorsal root ganglia (DRG) from neonatal mice were collected in ice-cold PBS 
and frozen in OCT (Sakura). Cryosections were cut with 12μm thickness. In situ hybridisation was 
performed with DIG-labeled probes as described (Muller et al. 2005) 
 
Patch-clamp electrophysiology and data analysis 
Whole-cell patch-clamp recordings were performed on DRG cultures from P7-P15 mice as previously 
described (Hu &Lewin 2006) and 100ng/µl NGF was added to the culture medium. Recordings were 
done 4-24 h after plating, using borosilicate capillaries with a resistance of 5-8MΩ. For VGSC 
recordings, cells were perfused with extracellular solution containing (in mM): 140 NaCl, 4 KCl, 1 
MgCl2, 2 CaCl2, 4 Glucose, 10 HEPES (pH 7.4) and pipettes were filled with solution containing (in 
mM): 122 KCl, 10 NaCl, 1 MgCl2, 1 EGTA, 10 HEPES (pH 7.3). PI-PLC (Prozyme) was applied with 
10µg/ml for 1h at 37 °C. TTX experiments were performed with 0.5 µM TTX. Membrane potentials 
were kept at -60 mV, prepulsed to -120 mV for 150 ms and depolarised from -50 to +40 mV for 50 ms 
in increments of 10 mV. For current clamp analyses, neurons were held at resting membrane potential 
and current injection was increased from 80 pA in 80 pA increments. For VGCC recordings, the bath 
solution was replaced with (mM): 140 TEA-Cl, 2 CaCl2, 10 HEPES, 10 glucose and 100 nM TTX, pH 
7.4 with TEA-OH. The pipette solution contained (mM): 120 CsCl, 4 MgCl2, 10 HEPES, 10 EGTA, pH 
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7.3 with CsOH. Currents were activated by 100 ms depolarisation pulses from a holding potential of -
80 to 0 mV with 10 s interval. Recordings were performed using an EPC10 amplifier (HEKA) at a 
sampling rate of 50 kHz. The series resistance was compensated for 40–60%. Data acquisition and 
analysis were performed with Patchmaster and Fitmaster software (HEKA Electronics, Darmstadt, 
Germany).  
 
Skin-nerve assays 
Single afferent units of the saphenous nerve from adult mice were identified using a mechanical 
stimulus (Milenkovic et al. 2008). C-fibres were subsequently examined for responsiveness to a cold 
ramp in which the temperature decreased from 30-0 °C. Experiments were carried out blind, i.e. the 
genotypes of the mice were not known to the experimenter. Cold stimuli were delivered with a 
computer-controlled Peltier device in contact with the skin receptive field.  
 
Electroporation and immunostaining of DRG cultures  
DRG neurons were isolated from an adult mouse and cultured as previously described (Hu &Lewin 
2006). Two hundred µg/ml of biotinylated IB4 (Vector labs) were used for IB4 live-stainings. DRGs 
were electroporated (Amaxa) with 5µg of plasmid CS2-t-MrVIa and 0.5µg of CS2-EGFP and plated on 
poly-L-lysin-laminin coated coverslips. One day later, cells were fixed with 4% PFA and washed in 
PBS. 3% goat serum was used for blocking. The following antibodies and markers were used: mouse 
anti-flag (Sigma) at 1:1000, wheat germ agglutinin (Molecular probes) at 1:200 (5µg/ml), goat-anti-
mouse-Alexa633 (Molecular probes) at 1:400. Pictures were taken on a Zeiss LSM confocal 
microscope.  
Transfection and Immunoprecipitation in HEK293-T Cells  
HEK293-T cells were transfected with the CS2-t-MrVIa expression vector using lipofectamine 2000 
(Invitrogen) according to manufacturer instructions. Immunoprecipitation with flag agarose beads 
(Sigma) and Western Blot assays were performed as described (Ibañez-Tallon et al. 2002). 
Immunostaining of spinal cord sections  
Mice (n=1 per genotype) were anaesthetized by intraperitoneal injection of 500µl of 5mg 
Ketavet/200µg Rompun in saline. Reflex responses such as limb withdrawal to paw pressure were 
used to indicate the need for a further dose of anaesthetic. Mice were then perfused with 4% PFA and 
cryosections were cut with 14 µm thickness. Mouse sections were blocked with 3% goat serum in 
PBS. The following antibodies and marker were used for immunostaining: rabbit-anti-subP (Zymed 
laboratories) at 1:1000, isolectinB4-Alexa-488 (Vector laboratories) at 1:500 and horse-anti rabbit-
Alexa594 (Molecular probes) at 1:1000. 
Calcium imaging  
Standard Fura-2-based ratiometric calcium imaging was used to record responses of DRG neurones 
cultivated from either WT or Tg-t-MrVIa mice (2-5 weeks of age) to application of different TRP 
channel agonists: capsaicin (TRPV1, 100 nM, 30 seconds), menthol (TRPM8, 100 mM, 30 seconds) 
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and cinnamaldehyde (TRPA1, 100 mM, 30 seconds). 40mM KCl (10 seconds) was applied at the end 
of experiments and only cells exhibiting a robust response were analyzed. An inverted microscope 
(Zeiss Observer A1) equipped with MetaFluor photonics imaging system, including Polychromator V, 
and a CoolSNAP ES camera (Visitron) was used for cell imaging. Mouse genotype was unknown to 
the experimenter.   
Frog surgery and oocyte recordings  
Xenopus laevis female frogs (n= 5) were anaesthetized by immersion for 30 minutes in a 0.35% 
Tricaine (Roth) solution until the animals were completely immobile and no reflex limb withdrawal was 
detected anymore. Before surgery frogs were rinsed in water and kept on ice during the surgery 
procedure. A relatively small piece of ovary was taken after performing a 1-2 cm long abdominal 
incision through the overlying skin and a second incision through the muscles. The muscular incision 
was closed with DS16-5USP re-absorbable sterile surgical thread (Catgut GmbH). The skin incision 
was closed with DS16-5USP non-absorbable sterile surgical thread (Catgut GmbH) and removed at 
the next surgery. After surgery frogs were kept for one day of observation in the laboratory before 
being returned to the main aquarium. The preparation of Xenopus laevis oocytes, cRNA transcripts 
and two electrode voltage clamp recordings were conducted as described previously (Ibañez-Tallon et 
al. 2002). VGSC subunit cRNAs alone or with tethered toxins (ratio channel:toxin was 1:4) were 
injected in oocytes and recorded 3-5 days later. 
Electron microscopy 
Mice (n=2 per genotype) were anaesthetized by intra-peritoneal injection of 500µl of 5mg 
Ketavet/200µg Rompun in saline. Reflex responses such as limb withdrawal to paw pressure were 
used to indicate the need for a further dose of anaesthetic. Saphenous nerves were isolated from mice 
which had been perfused with 4% paraformaldehyde and postfixed in 4% paraformaldehyde / 2.5% 
glutaraldehyde in PBS. Following treatment with 1% OsO4 in 0.1M phosphate buffer for 2h for 
osmication, tissue samples were dehydrated in a graded ethanol series and propylene oxide and 
embedded in Poly/BedR 812 (Polysciences, Inc., Eppelheim, Germany). Semithin sections (1μm) 
were stained with toluidine blue. Ultra-thin sections (70nm) were contrasted with uranyl acetate and 
lead citrate. The numbers of nonmyelinated and myelinated axons in the saphenous nerve of wild-type 
and transgenic mice were determined by counting of 12 random fields under the electron microscope 
and normalising to total cross-sectional nerve area observed in semi-thin sections. 
Behavioural experiments 
Mice were backcrossed to C57/BL6/J for at least five generations. Motor coordination: Motor 
coordination was assessed by placing the mice on an accelerating rotarod apparatus (Ugo Basile, 
Italy). Animals were scored for time to fall. Thermal nociception: Thermal latency was determined 
using the Plantar test (Ugo Basile) (Hargreaves et al. 1988). 15min after placing the mice in the 
Plexiglas chamber a high intensity light beam was directed at the plantar surface of the hindpaw. 
Movement of the paw stopped the light beam and the latency was indicated on a digital screen. 
Measurements were made five times on each paw and mean values were used for statistical analysis. 
Mechanical nociception: Mechanical sensitivity was determined using a dynamic plantar 
aesthesiometer (Ugo Basile, Milan, Italy). All animals were acclimatised to the behavioural testing 
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apparatus for 15min. An increasing mechanical force (1g/s) was applied to the plantar surface of the 
mouse hindpaw. Each paw was measured five times and mean values of the applied forces  were 
determined and used for statistical analysis. Cold nociception: Mice were placed onto a Peltier-cooled 
plate maintained at 00C ± 10C. The number of lickings and jumpings were determined during 90s. 
Preferential heat test: Mice had free access to two plates kept at 100C and 300C. The time spent on 
each plate was measured. Inflammatory pain: Mice (n=10 per genotype) were anaesthetized by 
isofluran inhalation. 30µl of 2% carrageenan in saline (Fluka) was injected into the plantar surface of 
the mouse right hindpaw to induce inflammatory hyperalgesia. On the following 3 days mice were 
tested for responses to heat and mechanical stimuli as described for the acute pain studies. Mice were 
sacrificed by placing in a box filled with 100% CO2 at the termination of the tests. 
Statistical Analysis 
Results are presented as means ± SEM. Unpaired t-tests or two-way ANOVAs were used when 
indicated. P < 0.05 was considered statistically significant. 
 
 
 
 
 
Results 
 
To generate a membrane-tethered isoform of MrVIa (t-MrVIa) we inserted a nucleotide sequence 
coding for the mature toxin between the sequences coding for a secretion signal and a 
glycophosphatidylinositol (GPI) anchor signal (Ibañez-Tallon et al. 2004) (Fig. 1A). Tethered toxin 
expression in nociceptors was achieved by Bacterial Artificial Chromosome (BAC) transgenic 
methodology (Gong et al. 2002) using genomic DNA that contains the Scn10a nociceptor-specific 
gene encoding for  the Nav1.8 VGSC α-subunit. Fig. 1B shows the diagram of the BAC containing the 
Scn10a gene and the homology boxes for recombination with the modified shuttle vector containing 
the t-toxin cassette. Four transgenic founder lines were identified by Southern blotting (Fig. 1C). 
Comparison of the endogenous Scn10a allele to the transgene band indicated that transgenic lines 2 
and 27 had the highest BAC transgene copy number. We encountered breeding problems with 
transgenic line 27 in that very few transgenic mice were born, which may have been a non-specific 
effect due to the size or the site of transgene insertion. We thus used line 2 (Tg(Scn10a-t-MrVIA)2Iit 
referred to hereafter as Tg-t-MrVIa mice) for all further experiments.  
Tg-t-MrVIa mice express t-MrVIa and Scn10a in DRGs, but not in other tissues along the 
nociceptive pathway whereas wild type littermates showed comparable levels of Scn10a transcripts in 
DRGs, but lacked t-MrVIa expression (Fig. 2A). As expected from the developmental pattern of 
Scn10a (Benn et al. 2001), in situ hybridisation indicated that t-MrVIa transcripts were present during 
embryonic development (Fig. 2B). In adult mice, t-MrVIa transcripts were detected in small diameter 
nociceptors, but not in large diameter sensory neurones (Fig. 2C).  
An important feature of membrane t-toxins is their cell-autonomous action. To assess, whether 
this property was maintained in vivo, we prepared DRG primary cultures, which contain a mixture of 
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sensory neurone types e.g. nociceptors and mechanoreceptors. Nociceptors were discriminated from 
mechanoreceptors by measuring AP configuration using the whole cell patch clamp technique (Fig. 2 
L, AP half peak width > 3.1 ms for nociceptors and < 0.8 ms for mechanoreceptors, Supplemental 
Table 2) and cell soma size (< 25 μm soma diameter for nociceptors and > 25 μm for 
mechanoreceptors; Supplemental Table 2) as previously described (Lawson 2002; Stucky &Lewin 
1999). Representative traces of VGSC currents, evoked by step depolarisation in voltage clamp mode, 
in nociceptors and mechanoreceptors of both Tg-t-MrVIa mice and wild type littermates are shown in 
Fig. 2D,G. Current-voltage relations indicated a significant reduction of VGSC currents in nociceptors 
of Tg-t-MrVIa mice compared to wild type littermates (Fig. 2E). In contrast, VGSC currents in 
mechanoreceptors of Tg-t-MrVIa mice were indistinguishable from those measured in 
mechanoreceptors of wild types littermates (Fig. 2G,H). Normalisation of  peak VGSC currents to cell 
capacitance indicated a 41.1 ± 9 % reduction of peak current densities in nociceptors of Tg-t-MrVIa 
mice compared to controls (wt: 413.7. ± 37.2 pA/pF, Tg-t-MrVIa: 243.5 ± 37.2 pA/pF, n=32 p < 0.05). 
However, no difference was observed in mechanoreceptors (wt: 306.9 ± 57.4 pA/pF, Tg-t-MrVIa: 
332.8 ± 26.8 pA/pF, n=9) (Fig. 2I and Supplemental Table 2). To exclude the possibility that the t-
MrVIA toxin could be affecting other ion channels present in nociceptors besides VGSC channels, we 
tested the functionality of VGCC (Fig. 2J,K) and TRP channels (supplementary Fig. 1).  Patch-clamp 
recordings of VGCC performed by step depolarisations, indicated no differences between nociceptors 
of Tg-t-MrVIA mice compared to wild type littermates (Fig. 2J). Current-voltage relationships did not 
differ between nociceptors of Tg-t-MrVIA  and wt mice with currents measured with increasing voltage 
steps from -50 to +40mV,  and maximal peak currents obtained at a voltage depolarisation from -50 to 
-10 mV (wt: -1.11 ±0.9 nA, Tg-t-MrVIa: -1.13 ±0.8 nA, n=10 each) (Fig. 2K) . The functionality and 
incidence of the TRP channels: TRPV1, TRPM8 and TRPA1 was measured by fura-2 based imaging 
of increases in [Ca2+]I in DRG neurones through the sequential application of the specific activators: 
capsaicin, menthol and cinnamaldehyde  (supplementary Fig. 1A,C). No significant differences in the 
percentage of DRG neurons responding to each agonist were observed between Tg-t-MrVIA mice 
compared to wild type littermates (capsaicin: wt: 35.8 ± 8.1 %, Tg-t-MrVIA: 35.5 ± 5.1, menthol wt: 
15.3 ± 5.6 %, Tg-t-MrVIA: 13.8 ± 4.0, cinnamaldehyde: wt: 10.1 ± 6.6 %, Tg-t-MrVIA: 11.6 ± 6.2, n = 4 
for both genotypes) (supplementary Fig. 1B,D). These results show that these ion channels are not 
non-specifically affected by genetic expression of the t-toxin in these neurons. Other parameters, such 
as voltage-gated potassium outward currents (Fig. 2F) and the resting membrane potential (wt: -51.9. 
± 1.95 mV, Tg-t-MrVIa: -52.7 ± 1.1 mV, n=32 ; Supplemental Table 2), were also unaltered in 
nociceptors of Tg-t-MrVIA mice compared to controls. These results indicate that t-MrVIa is cell 
autonomous and specific for VGSCs in vivo.   
Nociceptors, electroporated with t-MrVIa and EGFP, showed Flag immunolabeling at the cell 
membrane, which was abolished after treatment with phosphatidylinositol-specific phospholipase C 
(PI-PLC) that cleaves GPI-anchored proteins from the cell surface (Fig. 3A). Immunoprecipitation 
assays indicated that t-MrVIa is enriched in membrane fractions and cannot be detected in the culture 
medium (Fig. 3B). VGSC currents were measured before and after treatment with PI-PLC. Total peak 
current densities in nociceptors of Tg-t-MrVIa mice were restored to 87.5 ± 8.6% of control currents 
after PI-PLC (Fig. 3C). Taken together, these data demonstrate that t-MrVIa acts at the cell surface to 
block VGSCs.  
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A number of studies have reported that native MrVIa and its close relative MrVIb preferentially 
block TTX-R VGSCs, but at higher concentrations a subset of TTX-S channels are also affected by 
these toxins ((Daly et al. 2004) and Supplemental Table 1). In Supplemental Table 1 we have 
presented an overview of the reported VGSC blocking capabilities of the native soluble forms of μO-
conotoxins MrVIa and MrVIb in different experimental systems. These studies show that while the 
native conotoxins MrVIa/b are not highly selective for only one type of VGSC, they can discriminate 
between TTX-R channels present in nociceptors, over TTX-S. Although the relative extent of the 
inhibition of VGSC current depends on the assay, and there is no direct comparison of all alpha 
subunits within one experimental set of data, it would seem that native MrVIa/b preferentially blocks 
Nav1.8   followed by Nav1.7, Nav1.4 and Nav1.2. To determine whether the modified MrVIa used in this 
study maintains the characteristics of the native soluble MrVIa form, we performed oocyte 
electrophysiological assays with t-MrVIa and different VGSC alpha subunits. These experiments show 
significant block of Nav1.2, but not of Nav1.1, Nav1.3 and Nav1.6 VGSC by t-MrVIa (Supplemental Fig. 
2) in agreement with the reported affinities of the soluble toxin (Supplemental Table 1). Thus our 
experimental evidence suggests that the tether does not change the specificity of the MrVIa toxin.   
We next used TTX to discriminate between TTX-R and TTX-S currents present in nociceptors. 
TTX-R currents in nociceptors of t-MrVIa transgenic mice show a  44 ± 7 % reduction compared to wt 
mice (wt: 284.3 ± 34.1 pA/pF, n=30, Tg-t-MrVIa: 158.6 ± 20.4 pA/pF, n=31), p < 0.5). This block was 
reversed by PI-PLC treatment thus demonstrating that the tethered toxin was responsible for this 
inhibition (PI-PLC: 243.6 ± 31.5 pA/pF, n=12) (Fig. 3C,D). We observed a non-statistically significant 
inhibition  (31 ± 13%; wt: 129.6 ± 22.1 pA/pF, Tg-t-MrVIa: 89.3 ± 16.6 pA/pF, p= 0.23) of TTX-S 
currents in nociceptors with a very large sample size (n=32 nociceptors recorded) (Fig. 3C). In addition 
the recovery of TTX-S currents after PIPLC enzymatic cleavage of the tether was not statistically 
significant as it was for TTX-R currents. Thus the changes in TTX-S currents observed in transgenic 
mice might be indicative of partial (but not statistically significant) antagonistic activity of the t-MrVIa on 
these channels (Fig. 3C). Furthermore, we used a pulse protocol that avoids any substantial 
contamination by Nav1.9, which undergoes ultraslow inactivation such that clamping the membrane 
potential for several minutes at at least -100 mV is required to release it from inactivation (Amaya et al. 
2006; Cummins et al. 1999). Given that we used a holding potential of -60mV while measuring TTX-R 
currents, similarly to the experiments performed with the soluble toxin (Daly et al. 2004), our results 
demonstrate a block of Nav1.8 TTX-R channels by t-MrVIA in vivo.  
We next tested the effect of t-MrVIa on isolectin-B4 positive (IB4+ve) nociceptors, which have 
a higher density of TTX-R currents (Dib-Hajj et al. 1998; Snape et al. 2010; Stucky &Lewin 1999). 
Voltage clamp analyses in DRG neurones live-labeled with fluorescently coupled IB4 indicated that the 
t-MrVIa mediated block was 48 ± 8 % in the IB4+ve neurone population (wt: 422.7 ± 57.0 pA/pF, n=10, 
Tg-t-MrVIa: 221.8 ± 33.2 pA/pF, n=12) and 48 ± 9 % in the IB4-ve population  (wt: 215.1 ± 33.6 pA/pF, 
n=20, Tg-t-MrVIa: 111.6 ± 19.2 pA/pF, n=19) (Fig. 3E and supplemmental Table 2). TTX-R peak 
current densities were indeed higher in IB4+ve neurones (Fig. 3E) consistent with the reported higher 
content of Nav1.8 in this cell population (Snape et al. 2010; Stucky &Lewin 1999).  We hypothesized 
that the t-toxin might have a stronger effect on IB4+ve nociceptors since the Scn10a gene promoter 
was used to genetically drive expression of the t-toxin. Therefore, we measured AP amplitudes in 
IB4+ve and IB4-ve nociceptors (Figure 3F). Current clamp assays revealed that IB4+ve but not IB4-ve 
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nociceptors from Tg-t-MrVIa mice had significantly reduced AP amplitudes (Δ=14.9 mV) (Fig. 3F and 
Supplemental Table 2). No significant changes in the number of myelinated or unmyelinated fibres (A-
fibres: wt: 711.8 ± 3.1, Tg-t-MrVIa: 714.8 ± 50.7, C-fibres: wt: 2920.6 ± 197.0, Tg-t-MrVIa: 2660.7 ± 
173.1; n=3 mice, Supplemental Fig. 3), and in the distribution of IB4+ve and IB4-ve nociceptor 
populations (n=2 mice, Supplemental Fig. 4) were observed. The central terminations in the outer 
laminae of the dorsal horn were also unchanged (Fig. 3G). In summary, t-MrVIa selectively reduces 
TTX-R VGSC currents in nociceptors in the absence of detectable morphological changes.  
 A battery of behavioural tests was performed on Tg-t-MrVIa mice. Motor activity and baseline 
sensitivities to noxious thermal and mechanical stimuli, as well as thermal hyperalgesia after 
inflammation, were normal (Supplemental Fig. 5, Fig. 4A). In contrast, mechanical hyperalgesia after 
inflammation, shown as the relative threshold for paw withdrawal before and after inflammation, was 
significantly reduced in Tg- mice with respect to wt mice (n=10 mice) (Fig. 4B), as was the nocifensive 
response to noxious cold (wt: 3.3 ± 0.9, Tg-t-MrVIa: 1.2 ± 0.4 number of licks and jumps during 90 
seconds on a 0°C plate) (n=10 mice) (Fig. 4C, Supplemental Movies 1,2). No differences in 
behavioural thermoreception were observed (Fig. 4D). Thus, our data demonstrate that Tg-t-MrVIa 
mice have strong and specific deficits in nociception. We next asked whether the behavioural deficits 
we observed can be explained by changes in the stimulus response properties of identified cutaneous 
nociceptors. We thus used the skin-nerve preparation to measure the firing frequencies of single cold-
sensitive C-fibres. Two types of cold-activated fibres were recorded when subjected to a cooling 
gradient. A low-threshold population that started firing at innocuous temperatures (~25 °C, Fig. 4E) 
and a high-threshold population that started to respond only below 10 °C (Fig. 4F).  While the firing 
frequency in the low-threshold population did not differ between wt and Tg-t-MrVIa mice (Fig. 4E), the 
high-threshold population had significantly decreased firing rates during the cold ramp (Fig. 4F). 
Maximal differences were observed around 0 °C in agreement with our observations on noxious cold 
evoked behavioural responses. The firing rates of C-fibres to noxious cold were significantly different 
in Tg-t-MrVIa mice, and were 4.5 ± 1.2 spikes/s (n=8) in wild type and 1.9 ± 0.5 spikes/s (n=4) in Tg-t-
MrVIa mice when the cold ramp reached 0 °C (Figure 4F). Thus our data indicate that TTX-R VGSC 
currents blocked by t-MrVIa in nociceptors are required both for nociception in the cold and for 
detection of noxious cold per se.  
 
 
 
Discussion 
This study establishes the utility of genetically encoded, cell-membrane anchored peptide toxins to 
dissect the contribution of VGSC conductances in a defined neuronal type in vivo, and thereby 
establish a causal link between cellular physiology and behaviour. We show that VGSC currents in 
nociceptors are cell-autonomously and selectively inactivated by t-MrVIa toxin and that this block can 
be reversed by enzymatic cleavage of the tether (Fig. 3). Within the targeted neuronal population, the 
t-toxin shows a high degree of specificity for TTX-R VGSCs and there was no evidence for 
compensatory changes in the activity of other ion channels present in the same neurones such as 
TTX-S VGSCs, VGCCs and TRP channels.  
 Detailed studies of Nav1.8 and Nav1.7 ion channel mutations have demonstrated the distinct 
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roles of these channels in vivo, and compensatory mechanisms that are activated in abnormal 
physiological states (Akopian et al. 1999; Nassar et al. 2004; Rush et al. 2006). For example, analyses 
of Nav1.8 knockout mice have shown that functional inactivation of Nav1.8 is accompanied by a 
significant upregulation (about twofold) of TTX-S currents and a compensatory shift of the steady-state 
inactivation due to over-expression of Scn9a transcripts encoding the TTX-S VGSC Nav1.7 (Akopian 
et al. 1999; Matsutomi et al. 2006). Here we asked whether a similar compensatory mechanism 
operates in Tg-t-MrVIa mice. As detailed above, partial inhibition of TTX-R currents in Tg-t-MrVIa was 
observed with no evidence of compensation by TTX-S currents. Interestingly the selective, but partial, 
block of TTX-R currents in the Tg-t-MrVIa mice described here resulted in pain related phenotypes 
such as reduced mechanical hyperalgesia and insensitivity to noxious cold, which have been 
previously observed in Nav1.8 null mutant mice and in in vivo models with selective inactivation of 
Nav1.8 (Akopian et al. 1999; Jarvis et al. 2007; Zimmermann et al. 2007). However, while cutaneous 
fibres of Nav1.8 null mutants show a significant reduction of menthol-sensitized cold responses 
(Zimmermann et al. Fig. 3G) and reduced firing rates when stimulated by constant mechanical 
pressure at low temperatures (Zimmermann et al.  Fig.3E/F), they do not show differences in cold-
induced discharge activity (Zimmermann et al. Figure S6A). In our study we show that cutaneous 
fibres of Tg-t-MrVIa mice have significantly reduced firing rates after stimulation with cold ramps (from 
25°C to 0°C) without the concurrent application of menthol, indicating that TTX-R VGSC currents 
sustain the ability of neurons to fire APs at very low temperatures. Thus the presence of TTX-R VGSC 
current iis not only responsible for the detection of mechanical stimuli in the cold, but also for the 
detection of noxious cold per se. The apparent discrepancy between our study and that of 
Zimmermann and colleagues might be attributed to the differences in the protocols used to measure 
cold-induced responses (a cooling ramp from 30°C to 10°C was used by Zimmermann et al., while we 
used a ramp from 25°C to 0°C degrees). Nonetheless when the cooling gradient reached 10°C we 
already observed reduced firing discharges in Tg-t-MrVIa mice (Fig 4E).  Since studies on Nav1.9-/- null 
mutants have not indicated any contribution of these channels to cold sensitivity (Amaya et al. 2006), 
the t-MrVIA mediated block of TTX-R currents resulting in cold insensitivity is presumably accounted 
for by blockade of Nav1.8 exclusively.  Studies on corneal C-fibres have shown that many cold 
sensitive afferents sustain discharge to thermal stimulation even when TTX is applied to the 
preparation (Brock et al. 1998). It is thus quite possible that the residual TTX insensitive current 
generated in the cutaneous endings of cold sensitive fibres in the skin of transgenic mice is sufficient 
to preserve afferent responses to mild cooling. Environmental changes to innocuous cold 
temperatures are detected by the menthol TRPM8 receptor (Bautista et al. 2007). However, when 
temperatures become painful Nav1.8 seems to be not only essential to maintain the excitability of 
nociceptors (Zimmermann et al. 2007), but based on our results the activity of Nav1.8 is also required 
for nociceptors to detect noxious cold temperatures.  
Nociceptor specific VGSC are important therapeutic targets and major efforts have been made 
to screen for specific molecules to block their function. For instance, conotoxins are already used as 
analgesic drugs. The MrVIa-related conotoxin MVIIa (commercialised as Prialt or ziconotide) is a 
specific antagonist of N-type VGCC, and is used to treat patients with extreme neuropathic pain that is 
insensitive to opioids (Thompson et al. 2006). In contrast to local application of such analgesic 
 12
peptides, delivered intrathecally via infusion pumps to avoid severe side effects due to diffusion of the 
toxin into the CNS, genetic delivery of tethered toxins to defined cell populations could become a 
viable alternate to prevent toxic effects and repetitive treatment. Future developments in the safety of 
gene transfer in humans offers considerable promise for the application of this novel tethered toxin 
technology to treat such extreme pain in humans. Extension of this approach to other peptide toxins 
together with the use of cell-specific genetic methods, may allow for specific intervention in defined 
neural circuits in vivo and therefore potential treatment of diseases caused by channelopathies. 
Given the importance of VGSC function for AP propagation, the extensive use of TTX for 
functional inactivation of CNS neurones in vivo, and our demonstration that t-MrVIa can cell-
autonomously inhibit VGSC function without resulting in misregulation of other ion channels or 
alterations in membrane potential, the extension of this methodology to other cell types and ion 
channels could provide a valuable new tool for the dissection of neural circuits. For instance, in a 
complementary study we have used other peptide toxins to block calcium influx through the VGCCs 
Cav2.1 and Cav2.2 (Auer et al. 2010). Thus, depending on the specificity and mode of action of the 
natural toxin of choice, this approach can be used for neuronal silencing by either inhibiting VGCC and 
block neurotransmitter release (Auer et al. 2010), or, as in this study, to inhibit  VGSC and reduce cell 
excitability. Novel peptide toxin blockers specific for VGSC types present in the CNS (Nav1.6 and 
Nav1.2) have yet to be discovered, but once such tools become available our strategy could be then 
applied to effectively inactivate AP generation in central neurons. Thus, our study extends the range of 
available methodologies that can be used for genetic studies of neural circuitry (Luo et al. 2008). 
Furthermore, our technique represents a validated means to address the contribution of specific ion 
channels and receptors to neuronal function and behaviour.  
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Figure legends 
 
Figure 1. Generation of BAC transgenic mice encoding membrane-tethered MrVIa toxin.  
A, Diagram showing t-MrVIa (green ribbon) including a flag epitope for immunodetection, a flexible 
poly (asparagine-glycine) linker (grey) and a GPI tether to the cell membrane. B, Schematic overview 
of the BAC modification by two-step homologous recombination. The modified shuttle vector (SV) 
contains the t-toxin cassette (green), flanked by a secretion signal (sec) and a polyA (pA), inserted 
between two recombination boxes (A and B in red) corresponding to the sequences flanking the 
initiator methionine of the Scn10a gene encoding the Nav1.8 VGSC subunit. Recombination (red lines) 
with the Scn10a BAC results in the modified BAC and the free shuttle vector. Scn10a gene promoter 
(black arrow), Scn10a exons (grey boxes), selection markers (dark green boxes), NcoI restriction sites 
for Southern blot (N), PI-SceI for BAC linearisation (P). C, Southern Blot of transgenic founder lines. 
Lines 2 and 27 showed the highest relative ratio of the transgene band (~2.3 kb) in comparison to the 
endogenous Scn10a allele (~1.5 kb) indicative of high BAC copy number. 
 
Figure 2. Cell autonomous inhibition of sodium currents in nociceptors of Tg-t-MrVIa mice.  
A, Co-expression of Scn10a and t-MrVIa transcripts in DRGs of Tg-t-MrVIa mice detected by RT-PCR 
analysis (sk: skin, bs: brain stem, co: cortex. B, In situ hybridisation on spinal cord sections of mouse 
embryos (E15) show strong t-MrVIa signal in DRGs but not in spinal cord (sc) of Tg-t-MrVIa mice. vc: 
vertebral column. Scalebar: 100 µm. C, t-MrVIa transcripts were detected by in situ hybridisation in 
nociceptors (arrow) but not mechanoreceptors (arrowhead) of Tg-t-MrVIa mice (2-4 weeks old). 
Scalebar: 50 µm. (D-H) Voltage gated currents were evoked by step depolarisations from -50 mV to 
+40 mV preceded by a hyperpolarizing prepulse from -60 to -120 mV to prevent inactivation. D,E, 
Representative traces and current-voltage relationships of inward currents indicate a significant 
reduction of sodium currents in nociceptors of Tg-t-MrVIa mice in comparison to wt littermates. F, 
Current-voltage relations of outward currents are not affected in nociceptors of Tg-t-MrVIa mice. G,H, 
Representative traces and current-voltage relations of inward currents, evoked by the same protocol 
shown in D, indicate no differences in mechanoreceptors of Tg-t-MrVIa mice and wt littermates. I, 
Peak VGSC current densities are significantly reduced in nociceptors of Tg-t-MrVIa mice (243.5±37.2 
pA/pF) with respect to wt mice (413.7 ± 37.2 pA/pF) (n=32 per group) and unchanged in 
mechanoreceptors (n=9 per group). p<0.05 two-way ANOVA in E,H; p>0.05 two-way ANOVA in F; 
p<0.05 t-test in I. J,K Representative traces (J) and current-voltage relations (K) of voltage gated 
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calcium currents, evoked by step depolarisations from -90 mV to +40 mV, indicate no differences in 
nociceptors of Tg-t-MrVIa mice and wt littermates (n=10 per group). L, Representative action 
potentials used to identify nociceptors and mechanoreceptors. 
 
Figure 3. T-MrVIa acts at the cell membrane and specifically blocks TTX-R currents with no 
compensatory upregulation of other VGSCs.  
A, t-MrVIa (flag: red) colocalizes with the membrane marker WGA (blue) in DRG neurons co-
electroporated with t-MrVIa and cytoplasmatic EGFP (upper panel). PI-PLC treatment eliminates flag 
immunoreactivity showing specific cleavage of the GPI-anchored toxin from the membrane (lower 
panel). Scalebars: 5 µm. B, Mammalian cells transfected with t-MrVIa show expression of the toxin in 
the membrane fraction by flag immunoprecipitation. C, Bar graph indicating the quantification of VGSC 
peak currents in nociceptors of wt and Tg-t-MrVIa mice (n= 32 cells per group) before and after TTX 
and PI-PLC treatment (n= 12 cells). The current densities of total VGSC and TTX-R currents are 
significantly reduced in Tg-t-MrVIa mice compared to wt mice, and significantly recover from t-toxin 
inhibition after PI-PLC treatment. TTX-S currents are not significantly affected in Tg-t-MrVIa mice. D, 
Current-voltage relationships of TTX-R currents indicate a significant inhibition of sodium currents in 
nociceptors of Tg-t-MrVIa mice in comparison to wt littermates (p<0.05 two-way-ANOVA), and no 
significant inhibition, with respect to wt, in Tg-t-MrVIa mice after PI-PLC treatment (p>0.05 two-way 
ANOVA). E, Peak current measurements in nociceptors treated with TTX and live-labeled with 
isolectin B4 indicates that IB4+ve  nociceptors display more TTX-R than IB4-ve nociceptors in wt and 
Tg mice and that t-MrVIa inhibition is significant in both subpopulations but more pronounced in 
IB4+ve  nociceptors (n=10–22 cells per group). F, The average amplitude of action potentials is 
significantly reduced in IB4+ve nociceptors (wt: 89.2 ± 2.3 mV, Tg-t-MrVIa: 74.3 ± 3.9 mV) but not in 
IB4-ve nociceptors and mechanoreceptors (t-test). (n=9-20per group). G, Immunodetection of 
substance P (red) and isolectin B4 (green) in dorsal spinal cord indicate no differences in afferent 
innervation between wt and Tg-t-MrVIa adult mice. p<0.05, t-test in C and E. 
 
Figure 4. Tg-t-MrVIa adult mice show reduced inflammatory hyperalgesia and insensitivity to 
cold pain.  
A, No differences in inflammatory thermal hyperalgesia induced by intraplantar injection of 
carrageenan were observed between wt and Tg-t-MrVIa mice (n=10 mice). B, Induced inflammation 
causes mechanical hyperalgesia in wt mice (peak at 4 h) and significantly reduced hyperalgesia in Tg-
t-MrVIa (n=10 mice). Dashed line indicates baseline pain response. C, Nocifensive cold responses 
scored during 90 s on a 0 °C cooled plate showed significantly reduced responses to noxious cold in 
Tg-t-MrVIa mice (n=10 mice). D, Temperature preference tests quantifying the time mice spent in 
either of two plates kept at 30 °C and 10 °C (n=8 mice). E, Histogram indicating the firing frequency of 
cold-sensitive C-fibres with a threshold >10 °C over a cooling gradient from 30-0 °C. The firing 
frequency did not differ between wt and Tg-t-MrVIa mice (fibres: n=8-12 fibres per group). F, 
Histogram indicating the firing frequency of cold-sensitive C-fibres with a threshold <10 °C responding 
to noxious cold stimuli over a cooling gradient from 30-0 °C. The firing frequency of cooling units with 
a threshold below 10 °C is significantly reduced in Tg-t-MrVIa compared to wt mice (fibres: n=4-8 
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fibres per group). The lower trace corresponds to the cold ramp stimuli used in both cases. p>0.05 
two-way ANOVA in A and E; p<0.05 two-way ANOVA in B and F; p<0.05 t-test in C. 
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